The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121337804 12133780 4 F 20160209 20160712 20160301 20160722 EXP JP-AMGEN-JPNCT2016025313 AMGEN 74.00 YR E M Y 51.00000 KG 20160722 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121337804 12133780 1 PS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 12 MG/KG Y 125147 6 MG/KG SOLUTION FOR INJECTION QOW
121337804 12133780 2 SS panitumumab PANITUMUMAB 1 Intravenous (not otherwise specified) 4.8 MG/KG, Q2WK 12 MG/KG Y 125147 4.8 MG/KG SOLUTION FOR INJECTION QOW
121337804 12133780 3 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WK U 0 400 MG/M**2 QOW
121337804 12133780 4 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS U 0 2400 MG/M**2 QOW
121337804 12133780 5 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 200 MG/M2, Q2WK U 0 200 MG/M**2 QOW
121337804 12133780 6 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2000 MG/M2, Q2WK U 0 2000 MG/M**2 QOW
121337804 12133780 7 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 85 MG/M2, Q2WEEKS 170 MG/M2 U 0 85 MG/M**2 QOW
121337804 12133780 8 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 65 MG/M2, Q2WEEKS 170 MG/M2 U 0 65 MG/M**2 QOW
121337804 12133780 9 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 2.5 MG, UNK U 0 2.5 MG
121337804 12133780 10 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 400 MG/M2 U 0 200 MG/M**2 QOW
121337804 12133780 11 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 400 MG/M2 U 0 200 MG/M**2 QOW
121337804 12133780 12 C AMLODIPINE /00972402/ AMLODIPINE BESYLATE 1 Oral 5 MG, UNK U 0 5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121337804 12133780 1 Rectal cancer
121337804 12133780 3 Rectal cancer
121337804 12133780 7 Rectal cancer
121337804 12133780 9 Diabetes mellitus
121337804 12133780 10 Rectal cancer
121337804 12133780 12 Hypertension

Outcome of event

Event ID CASEID OUTC COD
121337804 12133780 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
121337804 12133780 Anaemia
121337804 12133780 Decreased appetite
121337804 12133780 Dermatitis acneiform
121337804 12133780 Diarrhoea
121337804 12133780 Hypoglycaemia
121337804 12133780 Malaise
121337804 12133780 Neutrophil count decreased
121337804 12133780 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121337804 12133780 1 20160127 20160210 0
121337804 12133780 2 20160316 20160413 0
121337804 12133780 3 20160127 20160210 0
121337804 12133780 4 20160127 20160210 0
121337804 12133780 5 20160316 20160413 0
121337804 12133780 6 20160316 20160413 0
121337804 12133780 7 20160127 20160210 0
121337804 12133780 8 20160316 20160413 0
121337804 12133780 10 20160127 20160210 0
121337804 12133780 11 20160316 20160413 0